SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001493152-18-003532
Filing Date
2018-03-19
Accepted
2018-03-19 06:34:36
Documents
58
Period of Report
2017-12-31

Document Format Files

Seq Description Document Type Size
1 form10-k.htm 10-K 1909072
2 ex23-1.htm EX-23.1 5528
3 ex31-1.htm EX-31.1 13172
4 ex31-2.htm EX-31.2 13203
5 ex32-1.htm EX-32.1 11089
6 image_006.jpg GRAPHIC 13688
7 image_009.jpg GRAPHIC 22181
8 image_007.jpg GRAPHIC 24026
9 image_004.jpg GRAPHIC 54449
10 image_003.jpg GRAPHIC 51753
11 image_002.jpg GRAPHIC 12090
12 image_010.jpg GRAPHIC 58509
  Complete submission text file 0001493152-18-003532.txt   4242352

Data Files

Seq Description Document Type Size
13 XBRL INSTANCE FILE rttr-20171231.xml EX-101.INS 336546
14 XBRL SCHEMA FILE rttr-20171231.xsd EX-101.SCH 27840
15 XBRL CALCULATION FILE rttr-20171231_cal.xml EX-101.CAL 40527
16 XBRL DEFINITION FILE rttr-20171231_def.xml EX-101.DEF 101385
17 XBRL LABEL FILE rttr-20171231_lab.xml EX-101.LAB 235320
18 XBRL PRESENTATION FILE rttr-20171231_pre.xml EX-101.PRE 179020
Mailing Address 1880 CENTURY PARK EAST, SUITE 1000 LOS ANGELES CA 90067
Business Address 1880 CENTURY PARK EAST, SUITE 1000 LOS ANGELES CA 90067 310-203-1000
RITTER PHARMACEUTICALS INC (Filer) CIK: 0001460702 (see all company filings)

IRS No.: 263474527 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-37428 | Film No.: 18697439
SIC: 2834 Pharmaceutical Preparations